Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Codex DNA IncCommon Stock stock
Learn how to easily invest in Codex DNA IncCommon Stock stock.
Codex DNA Inc. Common Stock is a medical devices business based in the US. Codex DNA IncCommon Stock shares (DNAY) are listed on the NASDAQ and all prices are listed in US Dollars. Codex DNA IncCommon Stock employs 133 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Codex DNA IncCommon Stock
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – DNAY – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Codex DNA IncCommon Stock stock price (NASDAQ: DNAY)Use our graph to track the performance of DNAY stocks over time.
Codex DNA IncCommon Stock shares at a glance
|Latest market close||$7.26|
|52-week range||$6.16 - $25.70|
|50-day moving average||$7.96|
|200-day moving average||$11.74|
|Wall St. target price||$25.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.65|
Buy Codex DNA IncCommon Stock shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Codex DNA IncCommon Stock stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Codex DNA IncCommon Stock price performance over time
|1 week (2022-01-14)||-3.71%|
|1 month (2021-12-23)||15.06%|
|3 months (2021-10-22)||-23.98%|
|6 months (2021-07-23)||-56.86%|
|1 year (2021-01-19)||N/A|
|2 years (2020-01-19)||N/A|
|3 years (2019-01-19)||N/A|
|5 years (2017-01-19)||N/A|
Codex DNA IncCommon Stock financials
|Revenue TTM||$9.9 million|
|Gross profit TTM||$3.6 million|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||$221 million|
TTM: trailing 12 months
Codex DNA IncCommon Stock share dividends
We're not expecting Codex DNA IncCommon Stock to pay a dividend over the next 12 months.
You may also wish to consider:
- Danaher Corporation (DHR.US) (0.29% forward annual dividend yield)
Codex DNA IncCommon Stock overview
Codex DNA, Inc. , a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries. The company also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020.
Codex DNA IncCommon Stock in the news
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Codex DNA Showcases Potential of Groundbreaking SOLA Enzymatic DNA Synthesis Approach to Accelerate Development of Vaccines and Therapeutics
Frequently asked questionsWhat percentage of Codex DNA IncCommon Stock is owned by insiders or institutions?
Currently 52.653% of Codex DNA IncCommon Stock shares are held by insiders and 57.51% by institutions. How many people work for Codex DNA IncCommon Stock?
Latest data suggests 133 work at Codex DNA IncCommon Stock. When does the fiscal year end for Codex DNA IncCommon Stock?
Codex DNA IncCommon Stock's fiscal year ends in December. Where is Codex DNA IncCommon Stock based?
Codex DNA IncCommon Stock's address is: 9535 Waples Street, San Diego, CA, United States, 92121-2993 What is Codex DNA IncCommon Stock's ISIN number?
Codex DNA IncCommon Stock's international securities identification number is: US1920031010
More guides on Finder
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Ask an Expert